Updates in the Treatment of HR+ Breast Cancer : Episode 5
Opinion
Video
Potential With Individual Tumor Sequencing With Bespoke Testing Methodologies and ctDNA
A panel of experts discuss the potential of individual tumor sequencing with bespoke testing methodologies.
Video content above is prompted by the following:
- What are the available first- or second-line treatment options for HR+ advanced/metastatic breast cancer? (CDK4/6i +/- ET, etc.)
Related Videos
Related Content
